Raleigh PE firm builds portfolio with California acquisition


A private equity firm in Raleigh that's been active in M&A is investing in cell and gene therapy with its latest deal.

Previous The Ensign Group adds to its health care holdings in Kansas City area
Next It's mutual admiration for Winsupply and city of Moraine